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Abstract
The DNA mismatch repair (MMR) enzymes repair errors in DNA that occur during normal DNA metabolism or are induced by
certain cancer-contributing exposures. We assessed the association between 10 single-nucleotide polymorphisms (SNPs) in
5 MMR genes and oesophageal cancer risk in South Africans. Prior to genotyping, SNPs were selected from the HapMap
database, based on their significantly different genotypic distributions between European ancestry populations and four
HapMap populations of African origin. In the Mixed Ancestry group, the MSH3 rs26279 G/G versus A/A or A/G genotype was
positively associated with cancer (OR=2.71; 95% CI: 1.34–5.50). Similar associations were observed for PMS1 rs5742938 (GG
versus AA or AG: OR=1.73; 95% CI: 1.07–2.79) and MLH3 rs28756991 (AA or GA versus GG: OR=2.07; 95% IC: 1.04–4.12). In
Black individuals, however, no association between MMR polymorhisms and cancer risk was observed in individual SNP
analysis. The interactions between MMR genes were evaluated using the model-based multifactor-dimensionality reduction
approach, which showed a significant genetic interaction between SNPs in MSH2, MSH3 and PMS1 genes in Black and Mixed
Ancestry subjects, respectively. The data also implies that pathogenesis of common polymorphisms in MMR genes is
influenced by exposure to tobacco smoke. In conclusion, our findings suggest that common polymorphisms in MMR genes
and/or their combined effects might be involved in the aetiology of oesophageal cancer.
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Introduction
According to the GLOBOCAN 2008 database (http://
globocan.iarc.fr) oesophageal cancer is the 8
th most common
cancer worldwide and the sixth most common cause of cancer
death in the world, with more than 95 percent of the cases and
deaths occuring in developing countries. The highest incidence
rates were observed the Black population in Southern Africa and
Eastern Asia, with 16.3 and 14.2 cases per 100.000 population,
respectively, in contrast to Central America, Western and Central
Africa where 1.4, 1.2 and 1.1 cases per 100.000 were reported,
respectively. The latest report from the South African National
Cancer Registry confirms this high incidence rates among Black
Ancestry males and females with 8.0 and 4.5 cases per 100.000,
respectively, as well as among Mixed Ancestry males and females
with 10.4 and 4.4 cases per 100.000 population, respectively [1].
The main histological types of oesophageal cancer - squamous cell
carcinoma (OSCC) and adenocarcinoma (OAC) - are observed in
more than 95% of all oesophageal cancer cases, with OSCC being
the most predominant type in Africa and China [2,3].
Numerous alterations in certain key genes are linked with
altered risks for developing oesophageal cancer [4,5]. These genes
are mainly involved in DNA maintenance and repair, alcohol,
folate and carcinogen metabolism, cell cycle regulation and
apoptosis. However, only a few putative genes have been
consistently shown to correlate with disease susceptibility, includ-
ing ALDH2, CYP1A1 and MTHFR (reviewed in Hiyama et al. [5]).
This suggests that there are most likely additional background
genetic factors and interactions that contribute to oesophageal
pathogenesis [4]. Interestingly, from over 100 genetic association
studies conducted to date, only Liu et al. [6] study has focused on
highly polymorphic genes involved in the DNA mismatch repair
pathway and their role in oesophageal pathogenesis. Several
genome-wide association studies (GWAS) have also been con-
ducted in different populations, and study in European population
reported associations in the DNA repair gene HEL308 [7,8,9].
Moreover, MMR genes and their polymorphisms were reported to
contribute to the risk of developing lung or head and neck cancer;
both types of cancer share similar aetiology to oesophageal cancer
[10,11,12,13,14].
Genetic or epigenetic alterations in MMR genes can completely
or partially impair MMR efficiency and thus confer an increase in
the accumulation of replication errors (RER) in important cancer-
regulating genes, eventually leading to carcinogenesis [15]. Loss of
mismatch repair activity is manifested in a microsatellite instability
(MSI) phenotype. Studies investigating widespread microsatellite
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(MSI-L; where at least one microsatellite locus is altered) in 16–
67% of adenocarcinomas, whereas 2–60% of squamous cell
carcinoma tumors were MSI-L positive, with the highest MSI
frequencies observed in high-incidence populations, indicating
that MMR might be involved in the pathogenesis of the
oesophagus [16,17,18,19,20,21,22,23,24,25,26,27,28,29].
These reports prompted us to investigate common variants in
MMR genes and their role in susceptibility to oesophageal
squamous cell carcinoma in a high-risk population. We performed
a case-control study in two distinct ethnic groups of South
Africans, where we examined potential associations between 10
polymorphisms in 5 MMR genes (MLH1, MLH3, PMS1, MSH2
and MSH3) and oesophageal cancer. Moreover, SNP-SNP
interactions, as well as SNP-environment interactions were
investigated to further examine involvement of MMR system in
OC.
Results
Case-control Single-SNP Analysis
Characteristics of the two groups, Black and Mixed Ancestry are
provided in Table 1. In Black Africans, cases and controls were
similar in terms of age (P=0.109) and family history of cancer
(P=0.920). In the Mixed Ancestry group, cases compared with
controls were more likely to be males, smoke and drink alcohol
(P,0.0001 for all) and there was no significant difference in the
age distribution (P=0.472) between cancer cases and cancer-free
controls (Table 1). A combination of smoking and drinking habits
increased the risk for oesophageal cancer 5.46-fold in Black and
19.06-fold in Mixed Ancestry populations (P,0.0001 for each
population; Table 2).
Genotype and minor allele frequencies for SNPs are shown in
Table S1. For polymorphism rs26279 (MSH3), the minor G allele
occurred with a frequency of 32% in cases vs. 38% in controls in
the Mixed Ancestry group (P=0.044). The G allele of polymor-
phism rs5742938 (PMS1) had a frequency of 48% in cases and
57% in controls (P=0.007) in the Mixed Ancestry group. The
minor A allele of rs28756991 (MLH3) polymorphism occurred in
4% Mixed Ancestry controls vs. 9% in Mixed Ancestry cases
(P=0.001). No difference was observed among Black cases and
controls for analysed polymorphisms. Allelic distributions in Black
controls were in good agreement with those in the LWK or YRI
HapMap populations. All polymorphisms were found to be in
Hardy-Weinberg equilibrium (P.0.05) when examining Black
and Mixed Ancestry controls, separately. For ten SNPs under
study, more than 99% of samples were successfully genotyped. We
used logistic regression analysis to examine potential associations
between polymorphisms in MMR genes and oesophageal patho-
genesis before and after adjusting for age, gender, place of birth,
lifestyle habits and familial history of cancer. Adjusted odds ratios
are represented in Table 3. Dominant and recessive models for
minor alleles were considered for each SNP.
In the Mixed-ancestry group, the MSH3 rs26279G/G versus A/
A or A/G genotype was positively associated with cancer (adjusted
OR=2.71; P=5.71610
23). Similar associations were observed
for PMS1 rs5742938 (GG versus AA or AG: ajdusted OR=1.73;
P=0.027) and MLH3 rs28756991 (AA or GA versus GG: adjusted
OR=2.07; P=0.038). We found that all three associations
remained significant after correcting the P-values for multiple
testing, using the Benjamini-Hochberg method (rs26279: Pcor-
rected=0.027; rs5742938: Pcorrected=0.036; and rs28756991:
Pcorrected=0.027; [see Materials and Methods for details]). In
Black South Africans, we observed a marginal association
(P=0.086) for MSH3 rs1428030 polymophism (GG or AG versus
AA) with a 1.36-fold increase in cancer risk after adjusting for
other confounders. There was also evidence implying a reduced
cancer risk, with marginal significance, for MLH3 rs2875991 ‘A’
allele under recessive genetic model (adjusted OR: 0.14;
P=0.078). However, after correcting for multiple tests, signifi-
cance for both associations was lost. In addition, single-SNP
associations were also investigated only among squamous cell
carcinoma cases, excluding adenocarcinomas, however anaysis did
not provide additional or more significant results (Table S2).
Table 1. Characteristics of study subjects.
Characteristics Black Ancestry group Mixed Ancestry group
Controls (%) Cases (%) Controls (%) Cases (%)
Sample size 344 345 266 205
Histology OSCC 326 (94.5) 182 (88.8)
OAC 19 (5.5) 23 (11.2)
Age Mean (SD) 56.1 (16.2) 59.8 (11.3) 56.8 (16.5) 60.7 (10.2)
Gender Female 224 (65.1) 179 (51.9) 184 (69.2) 69 (33.7)
Male 120 (34.9) 166(48.1) 82 (30.8) 136 (66.3)
Smoking status No 227 (66.0) 136 (39.4) 104 (39.1) 16 (7.8)
Yes 117 (34.0) 209 (60.6) 162 (60.9) 189 (92.2)
Alcohol intake No 252 (73.3) 185 (53.6) 228 (85.7) 87 (42.4)
Yes 92 (26.7) 160 (46.4) 38 (14.3) 118 (57.6)
Place of birth Eastern Cape 159 (46.2) 284 (82.3) 14 (5.3) 18 (8.8)
Western Cape 154 (44.8) 35 (10.2) 220 (82.7) 170 (82.9)
Other 31 (9.0) 26 (7.5) 32 (12.0) 17 (8.3)
Family history of Cancer Yes 60 (17.4) 55 (15.9) 85 (32.0) 68 (33.2)
No 284 (82.6) 290 (84.1) 181 (68.0) 137 (66.8)
OSCC, oesophageal Squamous cell carcinoma; OAC, oesophageal adenocarcinoma.
doi:10.1371/journal.pone.0036962.t001
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Haplotype analysis was performed to further evaluate the role of
MMR genes in cancer aetiology. As shown in Table 4, three SNPs
in MSH3 (rs1805355, rs1428030 and rs26279) and two SNPs in
PMS1 (rs572938 and rs13404927) were used to generate
haplotypes. The frequency of Ars18053552Grs14280302Grs26279
haplotype of MSH3 was found to be significantly higher in black
controls (6.8%) than in black cancer cases (3.6%). However, the
observed inverse association was only marginally significant after
correcting for multiple tests (P1000=0.049). In the Mixed Ancestry
group, Grs57429382Grs13404927 haplotype of PMS1 was associated
with 1.612(95% CI: 1.2222.13) increase in OC risk, compared to
the reference A rs57429382G rs13404927 haplotype and remained
significant after correcting for multiple tests (P1000=0.011).
Observed PMS1 haplotype effect is entirely due to the association
of the PMS1 Grs5742938 allele observed in the single SNP analysis,
and no increase in significance is achieved by inclusion of the
variant rs13404927. There was no association between the three-
marker haplotype of MSH2 (rs17217772, rs3771280 and
Table 2. Effects of smoking and drinking on oesophageal cancer risk.
Black Ancestry group Mixed Ancestry group
Case Control AOR (95% CI) P-value Case Control AOR (95% CI) P-value
Tobacco smoking/alcohol consumtion
No/No 118 206 1.00 (reference) 13 100 1.00 (reference)
Yes/No 67 46 3.15 (1.85–5.36) 2.30610
25 74 128 3.76 (1.9227.35)
1.09610
24
No/Yes 18 21 2.32 (1.0824.98) 0.031 3 4 4.42(0.83223.60) 0.082
Yes/Yes 142 71 5.46 (3.2829.10) 7.3610
211 115 34 19.06 (8.96240.55)1.9610
214
doi:10.1371/journal.pone.0036962.t002
Table 3. Individual SNP effects on oesophageal cancer risk in two ethnic groups of South African population.
SNP Black Ancestry group Mixed Ancestry group
Genetic model AOR (95% CI) P-value AOR (95% CI) P-value
rs17217772, Asn127Ser GG vs AA/AG 1.73(0.13223.7) 0.681 ND
GG/AG vs AA 0.99(0.5821.69) 0.976 1.48(0.5923.73) 0.402
rs10188090, c.26352765G.A GG vs AA/AG 1.13(0.2425.44) 0.879 1.33(0.6522.69) 0.434
GG/AG vs AA 1.02(0.6521.60) 0.927 0.83(0.5621.34) 0.510
rs3771280, c.1510+118T.C TT vs CC/CT 1.99(0.4728.39) 0.350 0.94(0.5121.74) 0.839
TT/CT vs CC 1.07(0.7121.63) 0.735 0.80(0.5121.25) 0.325
rs26279, Ala1045Thr GG vs AA/AG 0.82(0.5221.30) 0.399 2.71(1.3425.50) 5.71610
23
GG/AG vs AA 0.93(0.6421.33) 0.674 1.32(0.8322.08) 0.238
rs1428030, c.1341-12568A.G GG vs AA/AG 0.90(0.4821.69) 0.747 1.56(0.5724.31) 0.390
GG/AG vs AA 1.36(0.9621.92) 0.086 1.13(0.7221.77) 0.605
rs1805355, Pro231Pro AA vs GG/GA 0.61(0.3221.15) 0.128 1.25(0.4723.36) 0.656
AA/GA vs GG 1.14(0.8121.61) 0.464 1.02(0.6521.59) 0.945
rs5742938, c.-21+639G.A AA vs GG/GA 2.29(0.6727.79) 0.182
AA/GA vs GG 1.04(0.7221.51) 0.843
(GG vs AA/AG)
a 1.73(1.0722.79) 0.027
(GG/AG vs AA)
a 1.32(0.7922.19) 0.281
rs13404927, c.699+3331G.A AA vs GG/GA 0.56(0.2321.38) 0.210 0.97(0.2423.92) 0.969
AA/GA vs GG 1.04(0.7221.50) 0.848 1.17(0.6921.95) 0.561
rs13320360, c.546-191T.C CC vs TT/CT 0.54(0.1721.73) 0.299 7.16(0.492104.49) 0.150
CC/CT vs TT 0.86(0.5921.26) 0.439 1.12(0.5622.18) 0.772
rs28756991, Arg797His AA vs GG/GA 0.14(0.0221.25) 0.078 ND
AA/GA vs GG 0.86(0.5721.31) 0.488 2.07(1.0424.12) 0.038
aMinor alleles are different between the two ethnic groups, hence genetic model indicated in brackets was investigated in Mixed Ancestry group. Significant
associations are printed in bold.
AOR, odds ratio adjusted for age, gender,smoking status, alcohol intake, place of birth and family history of cancer; CI, confidence interval; ND, not determined (zero
genotypes were found in one genotype group).
doi:10.1371/journal.pone.0036962.t003
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not shown).
Gene-gene Interaction Analysis
Possible cumulative effects of the SNPs were evaluated with
MB-MDR approach (see Material and Methods), as it is well
known that MMR enzymes function as heterodimers. Two, three
and four-order interaction models were considered and the results
are shown in Table 5. Data revealed best genetic interaction for
SNPs in MSH2 gene (rs3771280), MSH3 gene (rs1428030) and
PMS1 gene (rs13404927 and rs5742938), which was strongly
associated with increased risk of oesophageal cancer in Black
subjects. The frequency of the four-locus genotype CCrs3771280/
AGrs1428030/GGrs13404927/GG5742938 was significantly higher in
cases (18.6%) compared to controls (9.3%). In the Mixed Ancestry
group, three significant multigene interactions were predicted. A
three-order interaction MSH2 (rs3771280) * PMS1 (rs13404927) *
MSH3 (rs26279) and a four-order interaction, which included the
rs13320360 polymorphism in MLH1 gene, the rs10188090
polymorphism in MSH2 gene and the rs13404927 and
rs5742938 polymorphisms in PMS1 gene, were the most
significant and were hence regarded as the best models. The
multi-locus genotype CTrs37712802GGrs134049272AGrs26279 was
strongly associated with reduced risk for cancer (P=0.0028),
whereas the genotype TT/AA/GG/GG from interaction MLH1
(rs13320360) *MSH2 (rs10188090) *PMS1 (rs13404927) *PMS1
(rs5742938) was more than 2-fold higher in cancer patients than in
healthy individuals (Table 5). All three aforementioned interac-
tions, remained significant after 1000 random permutations test.
Gene-environment Interactions
To further investigate the role of MMR polymorphisms in
relation to environmental factors, individuals were stratified for
tobacco smoking habits. Three polymorphisms, that showed
association with oesophageal cancer risk in a single-SNP analysis
(see Table 3) were investigated in the stratified analysis based on
smoking. In the Mixed Ancestry group, polymorphisms MSH3
rs26279 and MLH3 rs28756991 remained associated with the
disease in smokers (Prs26279=0.004, and Prs28756991=0.011) in
contrast to non-smokers, where no significant associations were
observed (Table 6). In addition, three most significant gene-gene
interactions were investigate after stratifying both populations for
tobacco smoke exposure. Association of the four-locus genotype
CCrs3771280/AGrs1428030/GGrs13404927/GG5742938, identified in
Black subjects, was associated with OC in tobacco smokers
(P=0.007), whereas the significance of the association of the
TTrs13320360/AArs10188090/GGrs13404927/GGrs5742938 genotype
with OC in Mixed Ancestry subjects was lost (P=0.054). The
interaction MSH2 (rs3771280) * PMS1 (rs13404927) * MSH3
(rs26279) was only significant in smokers (P=0.004) in the Mixed
Ancestry group (Table 6).
Functional Analysis
To assess functional nature of OC-associated SNPs, that were
identified in this study, MSH3 and PMS1 mRNA levels were
examined in normal oesophageal biopsies from 47 OSCC patients
in correlation with rs26279 and rs5742938 genotypes, respectively.
No significant effects of the rs26279 and rs5742938 genotypes on
MSH3 and PMS1 expression levels, respectively, were observed
(Prs26279=0.340 and Prs5742938=0.954) (Fig. 1). In addition,
functional and structural effects of amino acid substitutions
Ala1045Thr (rs26279) in MSH3 and Arg797His (rs28756991) in
MLH3 were predicted using bioinformatic algorithms SIFT,
PolyPhen, and Align-GVGD. Bioinformatic tools predict whether
amino acid change will have neutral or damaging impact of the
protein, based on multiple alignment information and biophysical
characteristics of amino acids. Evolutionary sequence conserva-
tions were prepared from 26 MSH3 and 19 MLH3 protein
sequences from different species and served as an input for all
algorithms. In silico algorithm Align-GVGD predicted neutral
effect for variant Arg797His (rs28756991), whereas SIFT and
PolyPhen predicted it to have damaging impact on the proteins.
All three computational approaches were consistent in predicting
neutral functional nature of amino acid change Ala1045Thr
(Table S3).
Table 4. Estimated frequencies of haplotypes for the MSH3 and PMS1 genes.
Haplotype
Black
Ancestry
group Mixed Ancestry group
Control (%) Cases (%) OR
a (95% CI) P-value
Control
(%) Cases (%) OR
a (95% CI) P-value
MSH3 rs1805355 :
rs1428030 : rs26279
G A G 242 (35.1) 240 (34.7) 1.00 (reference) 127 (23.9) 114 (27.8) 1.30(0.95–1.78) 0.109
G A A 241 (35.0) 234 (33.9) 0.98(0.76–1.26) 0.897 278 (52.3) 192 (46.8) 1.00 (reference)
A G A 129 (18.8) 157 (22.7) 1.23(0.92–1.65) 0.179 58 (11.0) 52 (12.8) 1.30(0.86–1.97) 0.239
A G G 47 (6.8) 25 (3.6) 0.54(0.32–0.90) 0.022 41 (7.7) 37 (9.0) 1.31(0.81–2.11) 0.321
0.049
b
PMS1 rs5742938 :
rs13404927
A G 91 (13.2) 110 (16.0) 1.22(0.90–1.66) 0.195 266 (50.0) 158 (38.4) 1.00 (reference)
G G 463 (67.3) 457 (66.3) 1.00 (reference) 203 (38.1) 194 (47.3) 1.61(1.22–2.13) 9.0610
24
G A 119 (17.3) 110 (16.0) 0.94(0.70–1.25) 0.655 53 (10.0) 40 (9.8) 1.27(0.81–2.00) 0.346
0.011
b
Only haplotypes with a frequency greater than 3.0% are listed.
aORs were obtained with X
2 test.
bP-value was obtained with 1000 permutations test. OR, unadjusted odds ratio; CI, confidence interval.
doi:10.1371/journal.pone.0036962.t004
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Carcinogenesis is a multistep process involving genetic and
environmental risk factors. Common polymorphisms in many
genes, including those involved in DNA repair, have been shown
to predispose individuals to the disease. Genetic alterations in
microsatellite regions, a hallmark of a defective DNA mismatch
repair system, have been reported in oesophageal cancers. Despite
this, common polymorphisms in MMR genes have rarely been
studied in relation to OSCC susceptibility.
To estimate OSCC risk conferred by common polymorphisms
in MMR genes, we analysed 10 SNPs within 5 genes of the MMR
pathway in high incidence populations in South Africa. In light of
the common disease/common variant (CD/CV) hypothesis, SNPs
were selected on the basis of their different genotypic distributions
between African and non-African populations. Recent studies also
indicate that interplay between multiple polymorphisms plays a
key role in carcinogenesis; we therefore analysed SNP-SNP as well
as SNP-environment interactions in association with OC.
In this study, we identified three common polymorphisms that
were associated with OSCC in Mixed Ancestry individuals. Firstly,
the GG-genotype of polymorphism MSH3 rs26279 was positively
associated with the disease. Polymorphism MSH3 rs26279 has
been examined before, however with partially conflicting results
across studies. Conde et al. [30] observed no association with breast
cancer risk at the individual-SNP level in Caucasian females.
However, gene-gene interaction analysis in the same study showed
that multi-locus genotype AA/TC in MSH3 rs26279 *MSH6
rs1042821 interaction was associated with a decreased risk for
tumorigenesis, suggesting that rs26279 changes affinity of MSH3
protein to heterodimerize with MSH6. Furthermore, Liu et al. [6]
found no association between rs26279 and oesophageal adeno-
carcinoma in the Caucasian population, whereas a study by Hirata
et al. [31] reports that the GG or AG genotypes of MSH3 rs26279
polymorphism might be a risk factor for sporadic prostate cancer.
Table 5. Gene-gene interactions affect oesophageal cancer risk.
Order
a Best multigene interaction model Cases (%) Controls (%) P-value Risk
b
Black subjects
2 MSH3(rs1428030) *PMS1(rs5742938)
AA GG 28.9 38.4 0.00993 Low Risk
AG GG 32.2 25.6 0.05324 High Risk
P1000=0.089
3 MSH2(rs3771280) * MSH3(rs1428030) *PMS1(rs5742938)
CC AA GG 23.5 31.7 0.013038 Low Risk
CC AG GG 26.4 16.9 0.003077 High Risk
P1000=0.067
4 MSH2(rs3771280) * MSH3(rs1428030) * PMS1(rs13404927) *PMS1(rs5742938)
CC AA GG GG 13.0 22.4 0.0010468 Low Risk
CC AG GG GG 18.6 9.3 0.0007318 High Risk
P1000=0.049
Mixed-ancestry
subjects
2 MLH3(rs28756991) *MSH2(rs17217772)
AG AA 14.2 7.1 0.015846 High Risk
GG AA 77.1 86.5 0.003429 Low Risk
P1000=0.002
3 MSH2(rs3771280) * PMS1(rs13404927) * MSH3(rs26279)
CC AG AG 5.4 1.5 0.025807 High Risk
CT AG AG 5.4 1.5 0.079535 High Risk
CT GG AG 8.8 20.7 0.002852 Low Risk
CC GG GG 5.4 1.5 0.025807 High Risk
P1000=0.013
4 MLH1(rs13320360) *MSH2(rs10188090) *PMS1(rs13404927) *PMS1(rs5742938)
TT AG GG AA 6.3 12.8 0.02427 Low Risk
TT AA GG AG 6.8 12.8 0.03856 Low Risk
TT AA GG GG 15.1 6.4 0.00233 High Risk
P1000=0.049
NOTE: Individuals with multi-locus genotype of interest are compared against the rest of the individuals, which are considered as a reference group in each logistic
regression analysis. Low Risk, deceased risk for malignancy; High Risk, increased risk for malignancy.
aNumber of SNPs considered. Genotypes with most significant effects for each interaction (i.e. lowest P-value) are printed in bold. Statistical significance for each
interaction was further determined by 1000 permutations test (P1000).
doi:10.1371/journal.pone.0036962.t005
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MSI-L phenotype in sporadic colorectal cancer (reviewed by
Boland and Goel, 2010 [32]). It is possible that a similar
mechanism is responsible for frequently observed MSI-L pheno-
type in OSCC cases [23]. In our effort to assess functional nature
of identified SNP we performed expression analysis of MSH3 in
biopsy samples from patients and did not detect any correlation
between rs26279 genotypes and expression levels of MSH3 gene.
Moreover, in silico algorithms predicted neutral effect on the
proteins’ function and structure.
Secondly, we observed that a homozygous genotype for the G-
allele in the PMS1 rs5742938 polymorphism was associated with
cancer in Mixed-ancestry South Africans. This finding was further
confirmed by haplotype analysis in Mixed-ancestry subjects, where
haplotype Grs57429382Grs13404927 of PMS1 increased the risk for
cancer. The intronic change c.-21+639G.A (rs5742938) has not
been identified in association with any type of cancer before;
however, it was predicted by an UTRScan computational
algorithm as functionally non-significant [33]. According to our
biopsy expression analysis, genotypes of rs5742938 do not affect
the PMS1 mRNA expression levels. In the current literature the
role of MLH1-PMS1 complexes in mismatch repair remains
enigmatic.
Lastly, having one or two copies of an A-allele in MLH3
rs28756991 polymorphism was associated with increased risk for
developing OSCC. This finding was also supported by in silico
Table 6. Cumulative effects of genetic variation and tobacco smoking habits on oesophageal cancer risk.
Genetic variation Non smoking subjects Smoking subjects
Genotype Case/Control AOR (95% CI) Case/Control AOR (95% CI)
Single SNP
a rs26279 AA/AG 14/95 1.00 157/148 1.00
GG 1/8 0.78 (0.08–7.76) 32/12 3.14 (1.43–6.92)
a rs5742938 AA/AG 10/79 1.00 115/120 1.00
GG 5/25 3.15 (0.78–
12.74)
73/42 1.66 (0.99–2.78)
a rs28756991 GG 16/94 1.00 155/150 1.00
AA/GA 0/8 ND 34/12 2.69 (1.25–5.79)
Multi-order interaction
b (rs3771280) *(rs1428030) *(rs13404927) *(rs5742938) Other genotypes 115/202 1.00 166/110 1.00
CC/AG/GG/GG 21/25 1.39 (0.69–2.75) 43/7 3.37 (1.38–8.26)
a (rs13320360) *(rs10188090) *(rs13404927) *(rs5742938) Other genotypes 15/100 1.00 159/149 1.00
TT/AA/GG/GG 1/14 3.85 (0.24–
61.83)
30/13 2.12 (0.99–4.57)
a (rs3771280) *(rs13404927) *(rs26279) Other genotypes 16/93 1.00 171/123 1.00
CT/GG/AG 0/11 ND 18/39 0.36 (0.18–0.73)
aSNP or interaction was analysed in Mixed Ancestry subjects.
bSNP or interaction was analysed in Black Ancestry subjects.
AOR, odds ratios adjusted for age, gender, place of birth, alcohol consumtion and family history of cancer; CI, confidence interval; ND, not determined (zero genotypes
were found in one genotype group); Significant and border significant AORs are printed in bold.
doi:10.1371/journal.pone.0036962.t006
Figure 1. Correlations of rs26279 and rs5742938 genotypes with MSH3 and PMS1 mRNA expression levels. Expression levels (bars show
group medians) were determined in normal tissue samples from Mixed Ancestry OSCC patients. All values are normalized to GAPDH expression.
Kurskal-Wallis test was used to evaluate differences in expression levels between groups. Median values for rs26279 genotypes are: 0.012 (AA), 0.012
(AG) and 0.0081 (GG). Median values for rs5742938 genotypes are: 0.0074 (AA), 0.0094 (AG) and 0.0071 (GG).
doi:10.1371/journal.pone.0036962.g001
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change Arg797His (rs28756991) has potentially damaging impact
on the structure and function of MLH3 protein. This is the first
study reporting on MLH3 rs28756991 polymorphism (Arg797His)
and its relation to cancer risk; however, other functional
polymorphisms in the MLH3 gene have previously been shown
to confer cancer susceptibility. Michiels et al. [34] have shown that
SNP MLH3 rs175080 (Leu844Pro) was associated with an
increased risk for lung cancer in European Caucasians. A similar
finding was reported by Conde et al. [30] where interaction
between MLH3 rs175080 and MSH4 rs5745325 was associated
with increased risk for breast cancer in a Portuguese population.
Taken together, these reports support our finding that MLH3
could indeed be involved in the development of various types of
sporadic cancers, including OSCC. MLH3 is the third protein that
binds to MLH1, a key player in MMR apparatus, hence inefficient
assembly of MLH1–MLH3 complex could lead to low penetrating
oncogenic events.
In addition, significance for all three associations in the Mixed-
ancestry group persisted after correction for multiple tests and the
powers to detect the observed effect sizes were 90.47% (MSH3
rs26279), 84.88% (PMS1 rs5742938) and 86.71% (MLH3
rs28756991).
We failed to confirm similar associations in Black South
Africans at the single SNP level. The reason for lack of significant
associations in these individuals probably lies in different linkage
disequilibrium (LD) patterns among the two ethnic groups, rather
than different aetiologies of OSCC. African populations are most
probably the oldest populations in the world, since Africa is
believed to be the continent of origin for modern humans. In older
populations, the sizes of LD blocks are generally smaller, due to
more recombination events [35,36]. Hence, we can speculate that
the marker alleles, which were identified in the Mixed Ancestry
group (this is a young population arising from admixture of non-
Africans with indigenous African populations in the 17th century),
are in LD with the disease-causing alleles of MSH3, PMS1 and
MLH3 genes, whereas in Black Ancestry subjects (i.e. representa-
tives of an old population in Africa) the investigated alleles might
not be in LD with the disease alleles. However, association studies
in other ethnic groups are needed in support of this notion.
Furthermore, populations of African origin present an opportunity
to identify the true disease alleles, which are responsible for the
disease phenotype, by fine-mapping of the genetic regions that are
identified as disease-associated in non-African populations [37].
To further investigate the involvement of the MMR mechanism
in OSCC development, we explored possible gene-gene interac-
tions by MB-MDR, a dimension reduction method proposed by
Calle et al. [38]. In both groups, interaction analysis yielded several
statistically significant interactions. In Black individuals, a potential
four-order interaction MSH2 (rs3771280) * MSH3 (rs1428030) *
PMS1 (rs13404927) *PMS1 (rs5742938) demonstrated strong
association with increased risk for malignancy, whereas interaction
MSH2 (rs3771280) * PMS1 (rs13404927) * MSH3 (rs26279)
significantly decreased the risk for cancer in Mixed Ancestry
subjects (Table 5). Interestingly, results are consistent between the
two groups, since most significantly disease-associated interactions
were found between SNPs which are situated in MSH2, MSH3 and
PMS1 genes. Based on our data and the knowledge that MMR
activity is achieved by protein heterodimers, one could argue that
SNPs, affecting functionality of the ternary complex between
heterodimers MSH2–MSH3 and MLH1-PMS1, are an important
event in OSCC development. We also believe that there could be
many genetic interactions that affect assembly and functionality of
other MMR-heterodimers and therefore these need to be
identified. MLH3 (rs28756991) *MSH2 (rs17217772) interaction
was found to reduce the risk for OSCC in Mixed Ancestry
population (Table 5). Moreover, similar gene-gene interactions of
MMR genes have also been reported by Conde et al. [30] in
association with breast cancer susceptibility.
Our data also implies that pathogenesis of common polymor-
phisms in MMR genes are influenced by environmental exposures,
especially tobacco smoking. Similar findings have been reported
before in other cancer types, that share common aetiology to
oesophageal cancer. Hirao et al. [11] have shown association
between lung cancer and loss of heterozygosity (LOH) at MLH1
locus, with higher prevalence of LOH in smoking patients. Several
studies also suggest that the MLH1 rs1800734 polymorphism and
tobacco smoke exposure have a role in tumorigenesis of lung
cancer [12,13]. In our study, polymorphisms rs26279 (MSH3) and
rs2875661 (MLH3) appear to be involved in smoking-related
cancer, as they were only pathogenic among smoking individuals
in contrast to non-smoking, where no significant association was
observed (Table 6). The powers to detect the observed effect sizes
in tobacco-smoking cases of Mixed Ancestry group remained
sufficient for MSH3 rs26279 (97.53%) and MLH3 rs28756991
(85.05%), whereas borderline association of PMS1 rs5742938 with
cancer was underpowered at 64.06%. We are aware that only as
few as 16 non-smoking Mixed Ancestry cases were present in the
study, which considerably reduced the power to detect the
observed effect sizes in non-smokers. Therefore, to further support
the results obtained from Mixed Ancestry group, stratification
analysis was performed on the Black Ancestry group, where more
smoking and non-smoking individuals were enrolled. The four-
order interaction identified by MB-MDR was strongly associated
with cancer in smoking Black Ancestry individuals, in contrast to
non-smoking individuals of the same ethnic group, where no
association was observed (Table 6). This trend suggests that
defective MMR proteins - their activity may be compromised by
polymorphisms in MMR genes - might be inefficient in repairing
increased amounts of smoking-induced DNA adducts and/or
signalling for apoptosis in such DNA error events. Our results
support the data obtained by Dodd et al. [39], where it was
reported that genes involved in metabolism of nitrosamines and
DNA repair processes, including MMR, are dysregulated in
nasopharyngeal carcinoma (NPC). These authors proposed an
interplay between exogenous exposure to sources of nitrosamines
(such as dietary, tobacco smoke and other), and the ability to
efficiently metabolize nitrosamines or repair DNA damage
induced by reactive byproducts of nitrosamine metabolism in the
aetiology of NPC. Nitrosamine 4- (methylnitrosamino)-1-(3-
pyridyl)-1-butanone (NNK) is a potent carcinogen contained in
the cigarette smoke and was shown to induce cellular DNA
damage [40,41,42]. A study by Hou et al. [43] reported that Bcl2
enhances the frequency of NNK-induced mutations by down-
regulating MMR efficiency via disruption of the MSH2-MSH6
complex. Despite this, observed gene-environment interactions
associated with OSCC still warrant confirmation in a larger
independent study.
In addition, we confirmed from additive (in Black group) to
synergistic (in Mixed Ancestry group) risk effect of tobacco smoke
and alcohol combination on carcinogenesis as previously reported
by several other studies [44,45,46].
In conclusion, this study provides evidence that common
polymorphisms in MMR genes, are indeed involved in the
aetiology of OSCC. Cumulative effects of MMR-polymorphisms
were further shown to strongly contribute to cancer development
in both ethnic groups. In fact, our results imply that combined
effects of common polymorphisms in MMR genes might alter
MMR Polymorphisms and Oesophageal Cancer Risk
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first-hand tobacco smoke.
Materials and Methods
Study Subjects
The study population has been described elsewhere [47,48,49].
Briefly, a total of 1239 individuals were recruited from Black and
Mixed Ancestry population of South Africa. Black individuals
(n=689) were Xhosa-speaking South Africans (Xhosa-speakers
originated from the Bantu-speakers in Southern Africa), mostly
born in regions of the Eastern and Western Cape. Subjects
resulting from marriages between different ethnic groups, includ-
ing Western Europeans, the indigenous Khoisan, Bantu-speaking
Africans, Indonesians and Malaysians were considered to be of
Mixed Ancestry and were from Western Cape (n=471). The study
consisted of 550 diagnosed and histologically confirmed oesoph-
ageal squamous cell carcinoma or adenocarcinoma cases, who
were recruited between 2000 and 2010 from Groote Schuur
Hospital, Cape Town, Western Cape, South Africa. Cases were
either from Black or Mixed Ancestry ethnic group. There was no
restriction on recruitment criteria for age and gender of cases.
Controls (n=610) were healthy individuals without a previous
history of cancer and were recruited from the same population
groups and geographical area as the cases. Each participating
subject was interviewed to collect information on demographic
characteristics (age, gender, ethnicity), tobacco smoking and
alcohol consumption and family history of cancer. Subjects with
current or former smoking habits were classified as smokers.
Alcohol consumers were defined as individuals who consumed
more than 40 grams of alcohol per day. Family history of cancer
was considered positive for individuals with at least one first-degree
relative or two second-degree relatives having cancer. DNA was
extracted from frozen blood samples using standard protocols.
This study was approved by the University of Cape Town/Groote
Schuur Hospital Human Ethics Research Commitee. Written
informed consent was obtained from all participants recruited into
the study.
Selection of SNPs
Prior to genotyping, SNPs were selected from the HapMap
database (Phase II+III release #28, August 10) based on their
significantly different genotypic distributions between HapMap
population of European ancestry (CEU; Utah residents with
Northern and Western European ancestry from the CEPH
collection) and 4 HapMap populations of African origin (ASW:
African ancestry in Southwest USA; LWK: Luhya in Webuye,
Kenya; MKK: Maasai in Kinyawa, Kenya; and/or YRI: Yoruba
in Ibadan, Nigeria). We analysed 978 SNPs from 7 MMR genes
and found 27 candidate polymorphisms in 5 MMR genes with
significantly different genotypic distributions between African and
non-African HapMap-populations. From those SNPs, ten were
selected based on minor allele frequency (MAF .0.05) and their
possible functional properties (e.g. nonsynonymous SNPs). In
MSH2 three SNPs were selected (rs17217772, Asn127Ser,
c.380A.G; rs10188090, c.2635-765G.A; and rs3771280,
c.1510+118T.C), three in MSH3 (rs26279, Ala1045Thr,
c.3133G.A; rs1428030, c.1341-12568A.G; and rs1805355,
Pro231Pro, c.693G.A), two in PMS1 (rs5742938, c.
221+639G.A; and rs13404927, c.699+3331G.A), one in
MLH1 (rs13320360, c.546-191T.C), and one in MLH3
(rs28756991, Arg797His, c.2390G.A). No polymorphisms were
selected in MSH6 and PMS2 genes, since genotypic distributions of
polymorphisms were not significantly different between popula-
tions of African and non-African origin.
Genotyping
All SNPs were analysed by allele-specific quantitative PCR
assay [50,51] using Roche LightCylerH 480II instrument. Two
allele-specific primers, each specific for one of the two variants of
the analysed SNP, and a common primer for each SNP were
designed with WASP software [52]. To ensure better specificity,
allele-specific primers contained an additional mismatch at
penultimate position (second to last at 3’-end). Genotyping for
each sample was performed in two parallel 3mL PCR reactions,
one for each of the two alleles. Reactions contained 200 nM of one
allele-specific primer, 200 nM of common primer, 5 ng of
genomic DNA, and 1.5 mL KAPA
TM SYBRH FAST qPCR
Master Mix (26) (Kapa Biosystems). Amplification conditions
were as follows: initial denaturation for 3 min at 95uC; followed by
45 cycles of 5 sec at 95uC, 25 sec at 55–60uC (depending on the
SNP), and 5 sec at 72uC; finally, melting curve analysis was
performed. 10–20% of samples were re-genotyped to ascertain the
reproducibility of the assay. Complete concordance between
experiments was obtained. Primer sequences are available upon
request.
Statistical Analysis
Differences in demographic variables, lifestyle habits and
genotypic frequencies between cases and control subjects were
evaluated by using the Pearson’s Chi-Square (X
2) test. Genotype
data in control subjects from each ethnic group was checked for
Hardy-Weinberg equlibrium using Fisher’s exact test. All geno-
typic analyses were performed assuming dominant and recessive
models for the variant allele (i.e. minor allele in the control group)
of each SNP. Crude odds ratios (ORs) and odds ratios adjusted for
potential confounders (AORs), 95% confidence intervals (CIs) and
P-values were obtained from logistic regression analysis using the
SPSS (version 19) statistical package. For polymorphisms, the
common homozygote genotype in the control subjects was set as
the reference group. All reported values are two-sided, with P-
value ,0.05 considered as significant. Unadjusted significant P-
values were corrected for multiple tests under the number of
hypotheses tested (twenty per 10 SNPs in each ethnic group), using
the Benjamini-Hochberg (BH) method [53]. Power of the study
was calculated post-hoc using QUANTO (v1.2) [54].Haplotypes
were constructed from our population genotype data (including
missing genotypes) using PHASE (v2.1) software [55,56]. Phasing
of case and control haplotypes was performed separately. Samples
with $90% certainty of phase estimates were considered in the
analysis. In order to obtain reliable results, PHASE algorithm was
applied 100 times for each haplotype using the -x option as
instructed in the manual. The odds ratios (ORs) and their 95%
confidence intervals (CIs) were estimated by X
2 test. Significance
for overall haplotype distribution between controls and cases was
obtained with 1000 random permutations (P1000), where controls
and cases were phased together.
Gene-gene interactions were explored using the model-based
multifactor dimensionality reduction approach (MB-MDR) by
applying a ‘mbmdr’ R-package to our whole dataset, including
missing genotypes. General procedures of the three-step method
and ‘mbmdr’ guidelines are fully described elsewhere [38,57].
Briefly, in the first step of the algorithm, an association test
between each multi-locus genotype and the phenotype is
performed using logistic regression, where individuals with multi-
locus genotype of interest are compared against the rest of the
individuals (the latter are considered as the reference group in the
MMR Polymorphisms and Oesophageal Cancer Risk
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risk, low-risk and no-risk, accordingly. The second step of the
algorithm explores association of pooled genotypes in low-risk and
high-risk categories respectively, with the phenotype, using logistic
regression analysis. Again, the rest of individuals are considered as
the reference group. Significance of results is explored through
Wald statistics in the third step. In this study, multi-order
interaction with the most significant association between a specific
multi-locus genotype and the phenotype, was considered the best
model and was further adjusted for multiple testing by 1000
permutations approach (P1000). Stratification analysis for tobacco
smoking and alcohol consumtion was performed using the SPSS
package.
MSH3 and PMS1 Expression Analysis
Freshly frozen normal and tumour oesophageal biopsies were
obtained from 47 patients (Mixed Ancestry group) with histolog-
ically confirmed OSCC. Total RNA was extracted from homog-
enates of the tissue samples using RNeasy Mini Kit (Qiagen)
according to manufacturer’s protocol. cDNA was prepared from
1 mg of total RNA using ImProm-II
TM Reverse Transcription
System (Promega) and was subsequently used as a template in
quantitative PCR (qPCR). QPCR assays were performed with
SYBRH FAST qPCR kit (KapaBiosystems) in 10 mL volume
reactions containg 1 mL of cDNA and gene-specific primers for
genes GAPDH, MSH3 and PMS1, respectively. The following
primer-pairs were used: GAPDH-fw (59- GCC TGC TTC ACC
ACC TTC) and GAPDH-rv (59- GGC TCT CCA GAA CAT
CAT CC); MSH3-fw (59- GGC TCC TAT GTT CCT GCA
GAA G) and MSH3-rv (59- CCC TCT TCC TAG TTC ATC
CAA GAT); PMS1-fw (59- CCG TTA AGC ACA CCC AGT
CAG) and PMS1-rv (5’- CAC AGG TTC AAT ATT CTC TCC
CAC). All amplifications were performed as follows: initial
denaturation at 95uC for 3 minutes, followed by 45 cycles at
95uC for 30 seconds, and 60uC for 30 seconds and 72uC for 10
seconds. Analysed genes in all 47 samples were amplified in
triplicate using the Light Cycler 480II apparatus (Roche). MSH3
and PMS1 mRNA levels in each sample were normalized to
GAPDH expression in the same sample using the efficiency
corrected comparative Ct model:
?PCR efficiencies (E) were determined using LinRegPCR
software [58]. Differences in expression levels between groups
were evaluated with nonparametric Kurskal-Wallis test. Reported
P-values were two-tailed.
In silico Analysis of Amino Acid Substitutions
Predicting the putative effects of nonsynonymous SNPs on
protein function was performed using SIFT (Sorting Intolerant
from Tolerant) [59,60], PolyPhen (Polymorphism Phenotype) [61],
and Align-GVGD [62,63] algorithms. From multiple protein
sequence alignment, these bioinformatic tools provide prediction
scores, indicating the probability that a SNP is tolerant or
deleterious. SIFT predicts the functional importance of amino acid
change based on sequence homology and physical properties of
amino acids. Likewise, Align-GVGD combines the biophysical
characteristics of amino acids and protein multiple sequence
alignments, whereas PolyPhen predics the possible impact of an
amino acid substitution using sequence conservation, phylogenetic
and structural information characterizing the substitution. For all
algorithms 26 MSH3 and 19 MLH3 protein sequences, were used
as input sequences (Table S3). SIFT scores were designated as
tolerant (0.201–1.00), borderline (0.101–0.20), potentially intoler-
ant (0.051–0.10), or intolerant (0.00–0.05) [59,60]. PolyPhen
scores were classified as probably benign (0.000–0.999), borderline
(1.000–1.249), potentially damaging (1.250–1.499), possibly dam-
aging (1.500–1.999), or damaging ($2.000) [61]. For Align-
GVGD predictions, variants were classified according to AGVGD
graded classifiers used with the software (http://agvgd.iarc.fr/
agvgd_input.php).
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